Concepedia

Doina Elena Ganea-Motan

DE

Statistics

Publications

3

Citations

197

H-Index

3

Active since

2008

Affiliations

Duke Medical Center(Current)

Doina Elena Ganea-Motan is an author at Duke Medical Center specializing in lung cancer, clinical trials, and cancer therapeutics.

Top concepts

Publications per year

2008–2016

3

Publications

3

XM02 is superior to placebo and equivalent to Neupogen™ in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy

Auro del Giglio, Alexandru Eniu, Doina Elena Ganea-Motan et al. · BMC Cancer · 2008 · 105 citations · Full text

Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)

Suresh S. Ramalingam, Jeffrey Crawford, Alex Y. Chang et al. · Annals of Oncology · 2013 · 55 citations

, , +9

Randomized, Double-Blind Study Comparing Proposed Biosimilar La-Ep2006 with Reference Pegfilgrastim in Breast Cancer

Nadia Harbeck, Oleg Lipatov, Dmitry Udovitsa et al. · Future Oncology · 2016 · 37 citations · Full text

1–3 of 3